Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206216 · ClinicalTrials.gov registry record · NA
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03206216: Clinical Trial NA study, sponsored by Stanford University.
NCT03206216 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03206216, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This clinical trial studies how well Diode laser fiber type Selective Stimulator (DLss) works in predicting pain development in patients with ovarian cancer who are receiving chemotherapy. Stimulating of the pain nerve fibers in the skin with laser light stimulation may help to predict whether a patient will develop painful peripheral neuropathy, correlate with the severity of neuropathy during and after chemotherapy treatment, and may help to explain the mechanisms of chemotherapy-induced neuropathic pain (CIPN).
Interventions
- DIAGNOSTIC_TEST Diode Laser fiber type Selective Stimulator (DLss)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2017-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03206216
The ClinicalTrials.gov registry entry for NCT03206216 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diode Laser fiber type Selective Stimulator (DLss) is the first listed.
NCT03206216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03206216 about?
NCT03206216 is a clinical study titled "Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN". This clinical trial studies how well Diode laser fiber type Selective Stimulator (DLss) works in predicting pain development in patients with ovarian cancer who are receiving chemotherapy. Stimulating of the pain nerve fibers in the skin with laser light stimulation may help to predict whether a pat...
What is the current status of trial NCT03206216?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-08-04. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT03206216?
The interventions under investigation include: Diode Laser fiber type Selective Stimulator (DLss) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03206216?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.